Literature DB >> 1550399

Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features.

C A Brand1, M J Rowley, B D Tait, K D Muirden, S F Whittingham.   

Abstract

The clinical and serological features and HLA phenotypes are reported for 11 patients with coexistent features of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). All patients had a symmetrical small joint polyarthritis and features of SLE such as rash, photosensitivity, oral ulceration, serositis, cytopenia, and biopsy proved lupus nephritis. Eight had hypocomplementaemia. Autoantibodies were characteristic of the two diseases: all patients had rheumatoid factor and antibodies to double stranded DNA, eight (73%) had antibodies to collagen, and five (46%) had antibodies to Ro (SS-A). There was also an overlap of HLA phenotypes. Six patients were DR4 and seven were DR2 or DR3 positive, and of the five patients who were DR4 negative, four shared class I alleles often associated with DR4. If RA and SLE share a common autoimmune dysfunction, those patients who have the two diseases do so because they have genetic determinants of both.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550399      PMCID: PMC1005653          DOI: 10.1136/ard.51.2.173

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody.

Authors:  R G Hamilton; J B Harley; W B Bias; M Roebber; M Reichlin; M C Hochberg; F C Arnett
Journal:  Arthritis Rheum       Date:  1988-04

2.  Revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett
Journal:  Bull Rheum Dis       Date:  1989

3.  Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation.

Authors:  S Banerjee; H S Luthra; S B Moore; W M O'Fallon
Journal:  Clin Exp Rheumatol       Date:  1988 Oct-Dec       Impact factor: 4.473

4.  Cellular protein and RNA antigens in autoimmune disease.

Authors:  R M Bernstein; C C Bunn; G R Hughes; A M Francoeur; M B Mathews
Journal:  Mol Biol Med       Date:  1984-04

5.  Associations between HLA and antibodies to collagen in rheumatoid arthritis.

Authors:  M J Rowley; B Tait; T Doran; P Emery; I R Mackay
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

6.  Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis.

Authors:  A Chalmers; D Thompson; H E Stein; G Reid; A C Patterson
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  HLA and rheumatoid arthritis: a combined analysis of 440 British patients.

Authors:  D Jaraquemada; W Ollier; J Awad; A Young; A Silman; I M Roitt; M Corbett; F Hay; J A Cosh; R N Maini
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

9.  Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases.

Authors:  M G Cohen; J Webb
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

10.  'Rhupus' syndrome.

Authors:  R S Panush; N L Edwards; S Longley; E Webster
Journal:  Arch Intern Med       Date:  1988-07
  10 in total
  9 in total

Review 1.  Autoantibodies and overlap syndromes in autoimmune rheumatic disease.

Authors:  E C Jury; D D'Cruz; W J Morrow
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

Review 2.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

3.  Lupus arthropathy: a case series of patients with rhupus.

Authors:  Andrés Fernández; Gerardo Quintana; Federico Rondón; José Félix Restrepo; Alvaro Sánchez; Eric L Matteson; Antonio Iglesias
Journal:  Clin Rheumatol       Date:  2005-06-25       Impact factor: 2.980

4.  Rhupus; unusual presentations.

Authors:  Ora Shovman; Pnina Langevitz; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2015-05-28       Impact factor: 2.980

5.  Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M J Rowley; I R Mackay; C A Brand; J F Bateman; D Chan
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

6.  Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality.

Authors:  Murat Icen; Paulo J Nicola; Hilal Maradit-Kremers; Cynthia S Crowson; Terry M Therneau; Eric L Matteson; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

7.  [Rhupus syndrome: report of two cases].

Authors:  Imen Hachicha; Hela Fourati; Rim Akrout; Sofien Baklouti
Journal:  Pan Afr Med J       Date:  2012-06-26

8.  Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature.

Authors:  Ciro Manzo; Alberto Castagna
Journal:  Clin Pract       Date:  2021-07-01

9.  Rhupus arthropathy as the presenting manifestation in Juvenile SLE: a case report.

Authors:  Erbil Unsal; Ayse Ozgun Arli; Hakki Akman
Journal:  Pediatr Rheumatol Online J       Date:  2007-05-04       Impact factor: 3.054

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.